Marshall Wace, LLP SYROS PHARMACEUT Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
Number of Shares
159,584
Previous 24,818
543.02%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%